Loading...
OTCM
MYRX
Market cap27kUSD
Oct 08, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-98.33%
IPO
-99.97%
Name

Myrexis Inc

Chart & performance

D1W1MN
OTCM:MYRX chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-67.94%
Revenues
0
110,774,0005,456,00090,000185,00000
Net income
-12m
L-62.76%
-34,369,000-58,136,000-46,951,000-38,708,000-31,209,000-11,621,000
CFO
-13m
L-53.29%
12,180,000-60,682,000-40,368,000-33,455,000-27,774,000-12,972,000
Dividend
Feb 19, 20132.86 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.

Key people

Jonathan Couchman
President, Chief Executive Officer, Chief Financial Officer, Director · since 2013
Andrea Kendell
Treasurer, Secretary · since 2013
Michael Pearce
Independent Director · since 2013
Steven Scheiwe
Independent Director · since 2013
URL
https://myrexis.com/
IPO date
Jun 12, 2009
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

No data to show